Lelia M Fuentes

Title: Lelia M Fuentes: Innovator in Carbapenem Antibiotics

Introduction

Lelia M Fuentes is a prominent inventor based in Westfield, NJ (US). She has made significant contributions to the field of antibiotic development, particularly in the synthesis of carbapenem intermediates. With a total of 4 patents to her name, her work has been instrumental in advancing pharmaceutical research.

Latest Patents

Among her latest patents is the "Enantioselective process for producing 1-beta-methyl carbapenem." This patent describes a stereochemically controlled synthesis of intermediates that are crucial for producing 1-beta-methylcarbapenem antibiotic intermediates. The process involves reacting a beta-lactam with a chiral thia- or oxazolidinone enolate to preferentially produce a beta-methyl intermediate, which can then be transformed into a carbapenem antibiotic. Another notable patent is for "Chiral 1-.beta.-methyl-carbapenem intermediates." This multistep process allows for the selective obtaining of 1-.beta.-methylcarbapenem intermediates in high overall yield. The desired chirality is achieved through the hydrogenation of specific bicyclic beta-lactam ring structures, resulting in a mixture of alpha- and beta-methyl isomers with a high beta/alpha epimeric molar ratio.

Career Highlights

Lelia M Fuentes has established herself as a key figure in the pharmaceutical industry through her work at Merck & Company, Inc. Her innovative approaches to antibiotic synthesis have garnered attention and respect within the scientific community.

Collaborations

Throughout her career, Lelia has collaborated with notable colleagues such as Ichiro Shinkai and Thomas N Salzmann. These partnerships have further enhanced her research and contributed to the success of her projects.

Conclusion

Lelia M Fuentes is a distinguished inventor whose work in carbapenem antibiotic synthesis has made a lasting impact on the field. Her innovative patents and collaborations highlight her commitment to advancing pharmaceutical research and development.